Dandruff affects a significant portion of the population worldwide. This pesky scalp condition manifests as dry, flaky skin on the scalp and is often accompanied by itchiness. While its exact causes remain elusive, several factors have been identified as potential triggers of dandruff, including an overgrowth of yeast-like fungus called Malassezia, hormonal imbalances, stress, or certain skin conditions such as psoriasis or eczema. The discomfort caused by dandruff can be not only physical but also social and emotional, as individuals may feel embarrassed about visible flakes on their clothing or fear judgment from others. Fortunately, there are various treatment options available ranging from medicated shampoos containing antifungal agents to natural remedies like tea tree oil or apple cider vinegar rinses. Understanding this common issue allows us to empathize with those who experience dandruff while empowering them with knowledge and effective solutions for regaining a healthy scalp environment.
1.
Video: Liver transplant for patients with advanced colorectal cancer
2.
La interacción GBP3-STING en el glioblastoma coordina la respuesta deficiente al temozolomide.
3.
Blood tests can predict the risk of relapse after a bone marrow transplant in patients with acute myeloid leukemia.
4.
AI is useful in low-resource areas for triaging breast masses.
5.
Does pollution cause cancer?
1.
Methemoglobinemia in OR & ICU: Pathophysiology, Detection, and Management Review
2.
Bridging the Gap Between Cancer Treatment-Induced Cardiotoxicity and Regenerative Medicine
3.
Unlocking the Secrets of Neutrophils: Exploring Their Role in Immune Defense
4.
Unlocking the Potential of Onivyde: A New Hope for Cancer Treatment
5.
Beyond the Cure: The Emerging Role of Tissue-Agnostic Therapies in Palliative Oncology
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
2.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I
4.
Navigating the Complexities of Ph Negative ALL - Part VII
5.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation